C
Cynerio
Health Tech & Medtech · New York City, United States · Founded 2017
Develops a platform that enables healthcare providers to secure patient data and connected medical devices against cyber threats MoreLess
Cynerio operates in the healthcare cybersecurity market, focusing on securing Internet of Medical Things (IoMT) and other IoT devices used in healthcare settings. The company provides automated security solutions that identify, protect, and manage risks associated with these devices. Cynerio's primary clients are healthcare organizations, including small and rural hospitals, which are particularly vulnerable to cyber threats like ransomware attacks. The business model revolves around offering a cybersecurity platform that integrates IoT attack visibility with IT security enforcement, enabling healthcare providers to respond effectively to cyber threats without disrupting patient care. Cynerio generates revenue through subscription-based services and customized security solutions tailored to the specific needs of healthcare institutions. The company's solutions ensure patient safety, data confidentiality, and operational continuity by addressing critical vulnerabilities in IoMT and IoT devices.
Keywords: Healthcare IoT, cybersecurity, IoMT devices, ransomware protection, patient safety, data confidentiality, risk management, small hospitals, automated security, IT enforcement.
Company overview
Cynerio company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2017
- Headquarters
- New York City, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 60.8
Valuation & funding
Cynerio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jul 2025 | $0 | — | Axonius | ↗ |
| SERIES B✓Equity / VC | May 2021 | $30M | $120M | MTIP · Rafael Development Corporation · Consensus Business Group · Accelmed | — |
| SEED✓Equity / VC | Jan 2019 | $7M | $28M | MTIP · Rafael Development Corporation · Accelmed | ↗ |
| SEEDEquity / VC | Jan 2018 | $0 | — | Undisclosed | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $8.8M | 0% | 14 |
| 2025 | $8.8M | 0% | 20 |
| 2024 | $8.8M | 0% | 67 |
| 2023 | $8.8M | 0% | 62 |
| 2022 | $8.8M | +29.6% | 65 |
| 2021 | $6.8M | +104.5% | 61 |
| 2020 | $3.3M | — | 29 |
Growth signals
Cynerio website traffic
Latest recorded traffic for Cynerio is 770 monthly website visits, down 86.5% over the last three months. Cynerio's team declined 30% over the past year.
Comparisons
Cynerio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Cynerio's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on Cynerio's cap table
Sourced from Dealroom's funding and investor records.







Global footprint
Where Cynerio has talent and traffic
team presence
In the news
Latest news about Cynerio
Recent press, funding announcements, and product moves mentioning Cynerio — open to read from the original sources.
Market sentiment
What the market is saying about Cynerio
An AI-synthesized read of the highest-engagement posts about Cynerio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cynerio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







